Regulatory Science Fellowship Opportunity
LEARN MORE
Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
Featured Publications
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
No upcoming events. Subscribe to the CRS Newsletter
to keep up to date on news, updates, and future events.
Twitter @Harvardmit_CRS
Thank you to guest speaker Scott Steele @FDACBER for his in-depth presentation on emerging technologies in the regulatory science space, and being a part of a great final #RegSci Forum for this academic year. Thank you to all who attended and participated this afternoon!
The next #RegSci Forum, on June 4th, will feature guest speaker Scott Steele @FDACBER on "Regulatory Science and Emerging Technologies".
Register Here: https://rb.gy/8qoksz
Thank you to guest speaker @AndreaCoravos for presenting her unique perspective at today's #RegSci Forum, and sharing your story with our community! We greatly appreciate all who attended and participated in a great discussion!
The next #RegSci Forum, on May 7th, will feature guest speaker @AndreaCoravos on "From RegSci Classroom to Corporate Acquisition: The Story of HumanFirst".
Register Here: https://rb.gy/2xs5yt
Thank you to guest speaker Kenneth Getz @TuftsCSDD for a phenomenal presentation at today's #RegSci forum! Dr. Getz spoke extensively on trends of hyper-customization in medicine and its impact across a variety of groups and demographics. Thank you to all who participated.
The next #RegSci Forum, on March 5th, will feature guest speaker Kenneth Getz @TuftsCSDD. He will speak on "Clinical Trial Optimization in the Age of Hyper-Customization"
Register Here: https://rb.gy/kncvxy